share_log

Socket Mobile And 3 Other Stocks Under $3 Insiders Are Buying

Socket Mobile And 3 Other Stocks Under $3 Insiders Are Buying

Socket Mobile和其他3美元以下的股票內部人士正在買入
Benzinga ·  05/13 20:51

The Dow Jones index closed higher by over 100 points on Friday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

道瓊斯指數週五收盤上漲超過100點。當內部人士購買或出售股票時，這表明他們對公司前景的信心或擔憂。對細價股感興趣的投資者和交易者可以將此視爲他們整體投資或交易決策的一個因素。

Below is a look at a few recent notable insider transactions for penny stocks. For more, check out Benzinga's insider transactions platform.

以下是細價股最近幾筆值得注意的內幕交易。欲了解更多信息，請訪問Benzinga的內幕交易平台。

Comstock

康斯托克

  • The Trade: Comstock Inc. (NYSE:LODE) Chief Operating Officer William Joseph McCarthy bought a total of 15,000 shares at an average price of $0.26. To acquire these shares, it cost around $3,854.
  • What's Happening: On April 30, Comstock reported weaker-than-expected first-quarter sales.
  • What Comstock Does: Comstock Inc is engaged in technologies that efficiently use wasted and under-utilized natural resources to produce renewable energy and other products that contribute to balancing uses and emissions of carbon and enhance mineral and material discoveries.
  • 交易：康斯托克公司（紐約證券交易所代碼：LODE）首席運營官威廉·約瑟夫·麥卡錫以0.26美元的平均價格共購買了15,000股股票。收購這些股票的成本約爲3,854美元。
  • 發生了什麼：4月30日，康斯托克公佈的第一季度銷售額低於預期。
  • 康斯托克的所作所爲：康斯托克公司從事的技術可以有效利用浪費和未充分利用的自然資源來生產可再生能源和其他產品，這些產品有助於平衡碳的使用和排放，促進礦物和材料的發現。

Xeris Biopharma

Xeris Biopharma

  • The Trade: Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) Director John P. Schmid acquired a total of 5,400 shares at an average price of $1.91. To acquire these shares, it cost around $10,314.
  • What's Happening: On May 9, Xeris Biopharma posted downbeat quarterly results.
  • What Xeris Biopharma Does: Xeris Biopharma Holdings Inc is a biopharmaceutical company developing and commercializing unique therapies for patient populations in endocrinology, neurology, and gastroenterology.
  • 交易：Xeris Biopharma Holdings, Inc.（納斯達克股票代碼：XERS）董事約翰·施密德共收購了5,400股股票，平均價格爲1.91美元。收購這些股票的成本約爲10,314美元。
  • 發生了什麼：5月9日，Xeris Biopharma公佈了悲觀的季度業績。
  • Xeris Biopharma做什麼：Xeris Biopharma Holdings Inc是一家生物製藥公司，爲內分泌、神經病學和胃腸病學領域的患者群體開發和商業化獨特的療法。

GrafTech International

格拉夫科技國際

  • The Trade: GrafTech International Ltd. (NASDAQ:EAF) 10% owner WJS Investments Ltd acquired a total of 114,178 shares at an average price of $1.77. The insider spent around $202,438 to buy those shares.
  • What's Happening: On April 26, GrafTech International reported better-than-expected first-quarter financial results.
  • What GrafTech International Does: GrafTech International Ltd is a manufacturer of high-quality graphite electrode products essential to the production of EAF steel and other ferrous and non-ferrous metals.
  • 交易：GrafTech International Ltd.（納斯達克股票代碼：EAF）10％的所有者WJS Investments Ltd共收購了114,178股股票，平均價格爲1.77美元。知情人士花費了約202,438美元購買了這些股票。
  • 發生了什麼：4月26日，GrafTech International公佈的第一季度財務業績好於預期。
  • GrafTech International的所作所爲：GrafTech International Ltd是一家高質量石墨電極產品的製造商，這些產品對電弧爐鋼和其他黑色金屬和有色金屬的生產至關重要。

Socket Mobile

手機套接字

  • The Trade: Socket Mobile, Inc. (NASDAQ:SCKT) Director Charlie Bass acquired a total of 10,000 shares at an average price of $1.26. The insider spent around $12,644 to buy those shares.
  • What's Happening: On May 1, Socket Mobile posted better-than-expected quarterly sales.
  • What Socket Mobile Does: Socket Mobile Inc is a producer of data capture products.
  • 交易：Socket Mobile, Inc.（納斯達克股票代碼：SCKT）董事查理·巴斯共收購了1萬股股票，平均價格爲1.26美元。知情人士花費了約12,644美元購買了這些股票。
  • 發生了什麼：5月1日，Socket Mobile公佈的季度銷售額好於預期。
  • Socket Mobile做什麼：Socket Mobile Inc是數據採集產品的生產商。

Don't forget to check out our premarket coverage here

別忘了在這裏查看我們的上市前報道

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論